World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
80
Citations
27033
World Ranking
1611
National Ranking
31

Klas Kärre publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Klas Kärre sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 249 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Klas Kärre D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Klas Kärre sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 80 D-Index — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2002 - Member of Academia Europaea
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)

Overview

Klas Kärre is affiliated with the Karolinska Institute in Sweden. Their research primarily focuses on Immunology and Microbiology as well as Medicine. Within these fields, their work concentrates on subfields including Immunology, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, and Economics and Econometrics.

The main topics Klas Kärre explores include:

  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology
  • CAR-T cell therapy research
  • Immune cells in cancer
  • Ferroptosis and cancer prognosis

The scientist has contributed to several recent publications, notable examples include:

  • "Towards a cancer mission in Horizon Europe: recommendations," 2020, published in Molecular Oncology
  • "Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer," 2023, published in European Journal of Cancer
  • "Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade," 2021, published in Cancers
  • "Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer," 2021, published in The Journal of Pathology
  • "WITHDRAWN: Characterization of Patterns of Immune Cell Infiltration in NSCLC," 2020, published in Journal of Thoracic Oncology

Klas Kärre often collaborates with a consistent group of coauthors, including Johanna Sofia Margareta Mattsson, Johan Botling, Patrick Micke, Max Backman, and Artur Mezheyeuski. These collaborations have contributed to a number of publications.

Their research is regularly published in journals such as Journal of Thoracic Oncology, Cancers, bioRxiv (Cold Spring Harbor Laboratory), Regular and Young Investigator Award Abstracts, and Molecular Oncology, reflecting an established contribution across several venues.

Klas Kärre has been recognized with memberships in professional organizations including the Academia Europaea since 2002 and the European Molecular Biology Organization (EMBO).

Best Publications

  • In search of the 'missing self': MHC molecules and NK cell recognition.

    Hans-Gustaf Ljunggren;Klas Kärre

  • Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy

    Klas Kärre;Hans Gustaf Ljunggren;Gerald Piontek;Rolf Kiessling

  • Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.

    Hans-Gustaf Ljunggren;Klas Karre

  • Association of class I major histocompatibility heavy and light chains induced by viral peptides.

    Alain Townsend;Claes Öhlén;Judy Bastin;Hans-Gustaf Ljunggren

  • Empty MHC class I molecules come out in the cold

    H G Ljunggren;N J Stam;C Ohlén;J J Neefjes

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo

    Tadepally Lakshmikanth;Shannon Burke;Talib Hassan Ali;Silvia Kimpfler

  • Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice

    Petter Hoglund;Claes Ohlen;Ennio Carbone;Lars Franksson

  • Natural killer cell recognition of missing self

    Klas Kärre

  • A Signal Peptide Derived from hsp60 Binds HLA-E and Interferes with CD94/NKG2A Recognition

    Jakob Michaëlsson;Cristina Teixeira de Matos;Adnane Achour;Lewis L. Lanier

  • NK cell education: not an on-off switch but a tunable rheostat

    Petter Brodin;Klas Kärre;Petter Höglund

  • A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction

    Ennio Carbone;Giuseppina Ruggiero;Giuseppe Terrazzano;Carmen Palomba

  • The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells

    Petter Brodin;Tadepally Lakshmikanth;Sofia Johansson;Klas Kärre

  • NK Cells, MHC Class I Molecules and the Missing Self

    Unknown

  • A role for MHC class I molecules in synaptic plasticity and regeneration of neurons after axotomy.

    Alexandre L. R. Oliveira;Sebastian Thams;Olle Lidman;Fredrik Piehl

  • Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice

    Claes Öhlén;Gunilla Kling;Petter Höglund;Mona Hansson

  • Human NK Cells Selective Targeting of Colon Cancer–Initiating Cells: A Role for Natural Cytotoxicity Receptors and MHC Class I Molecules

    Rossana Tallerico;Matilde Todaro;Simone Di Franco;Cristina MacCalli

  • Effects of Human Cytomegalovirus Infection on Ligands for the Activating NKG2D Receptor of NK Cells: Up-Regulation of UL16-Binding Protein (ULBP)1 and ULBP2 Is Counteracted by the Viral UL16 Protein

    Alexander Rölle;Mehrdad Mousavi-Jazi;Mikael Eriksson;Jenny Odeberg

  • Allorecognition by NK cells: nonself or no self?

    Lorenzo Moretta;Ermanno Ciccone;Alessandro Moretta;Petter Höglund

  • YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.

    G E Piontek;K Taniguchi;H G Ljunggren;A Grönberg

  • Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems.

    Rolf Kiessling;Rolf Kiessling;Gyözö Petranyi;Klas Kärre;Klas Kärre;Mikael Jondal;Mikael Jondal

  • Host MHC class I gene control of NK-cell specificity in the mouse.

    Petter Hoglund;Jonas Sundback;Mats Y. Olsson-Alheim;Maria Johansson

  • Express yourself or die: Peptides, MHC molecules, and NK cells

    Klas Kärre

Frequent Co-Authors

Hans-Gustaf Ljunggren
Hans-Gustaf Ljunggren Karolinska Institute
Petter Höglund
Petter Höglund Karolinska Institute
Rolf Kiessling
Rolf Kiessling Karolinska Institute
George Klein
George Klein Karolinska Institute
Jakob Michaëlsson
Jakob Michaëlsson Karolinska University Hospital
Johan K. Sandberg
Johan K. Sandberg Karolinska University Hospital
Petter Brodin
Petter Brodin Karolinska Institute
Alain Townsend
Alain Townsend University of Oxford
Robert A. Harris
Robert A. Harris Karolinska Institute
Francesco Colucci
Francesco Colucci University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related degrees such as nursing can open diverse career pathways. Many professionals pursue advanced degrees like the Doctor of Nursing Practice (DNP), where understanding the dnp salary by specialty can help guide decisions based on earning potential and job demand.

Transitioning to specialized roles is also common. For example, nurses seeking to shift focus can explore acnp programs, which prepare family nurse practitioners to work in acute care settings—a key area of healthcare closely linked to immunological research and treatment.

For those starting out or changing careers, accelerated np programs online offer flexible pathways to becoming a nurse practitioner more quickly. Similarly, individuals with no prior nursing background can begin with online bsn programs for non nurses to enter the nursing field, which provides foundational knowledge valuable in immunology-related health professions.

Best Scientists Citing Klas Kärre

Trending Scientists

Recently Published Articles